Oral isotretinoin (Roaccutane) use during incisional surgery: safe or risky?

Two cases are presented that demonstrate normal wound healing following bilateral reduction mammoplasty, in young female patients taking therapeutic doses of Isotretinoin (Roaccutane). Review of the literature does not provide evidence that Isotretinoin impairs would healing, nor that it promotes hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Matthew J., Perkins, Darrell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116253/
https://www.ncbi.nlm.nih.gov/pubmed/35601983
http://dx.doi.org/10.1080/23320885.2022.2071275
_version_ 1784710080227180544
author Davies, Matthew J.
Perkins, Darrell
author_facet Davies, Matthew J.
Perkins, Darrell
author_sort Davies, Matthew J.
collection PubMed
description Two cases are presented that demonstrate normal wound healing following bilateral reduction mammoplasty, in young female patients taking therapeutic doses of Isotretinoin (Roaccutane). Review of the literature does not provide evidence that Isotretinoin impairs would healing, nor that it promotes hypertrophic or keloid scarring in surgical patients.
format Online
Article
Text
id pubmed-9116253
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-91162532022-05-19 Oral isotretinoin (Roaccutane) use during incisional surgery: safe or risky? Davies, Matthew J. Perkins, Darrell Case Reports Plast Surg Hand Surg Case Report Two cases are presented that demonstrate normal wound healing following bilateral reduction mammoplasty, in young female patients taking therapeutic doses of Isotretinoin (Roaccutane). Review of the literature does not provide evidence that Isotretinoin impairs would healing, nor that it promotes hypertrophic or keloid scarring in surgical patients. Taylor & Francis 2022-05-13 /pmc/articles/PMC9116253/ /pubmed/35601983 http://dx.doi.org/10.1080/23320885.2022.2071275 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Davies, Matthew J.
Perkins, Darrell
Oral isotretinoin (Roaccutane) use during incisional surgery: safe or risky?
title Oral isotretinoin (Roaccutane) use during incisional surgery: safe or risky?
title_full Oral isotretinoin (Roaccutane) use during incisional surgery: safe or risky?
title_fullStr Oral isotretinoin (Roaccutane) use during incisional surgery: safe or risky?
title_full_unstemmed Oral isotretinoin (Roaccutane) use during incisional surgery: safe or risky?
title_short Oral isotretinoin (Roaccutane) use during incisional surgery: safe or risky?
title_sort oral isotretinoin (roaccutane) use during incisional surgery: safe or risky?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116253/
https://www.ncbi.nlm.nih.gov/pubmed/35601983
http://dx.doi.org/10.1080/23320885.2022.2071275
work_keys_str_mv AT daviesmatthewj oralisotretinoinroaccutaneuseduringincisionalsurgerysafeorrisky
AT perkinsdarrell oralisotretinoinroaccutaneuseduringincisionalsurgerysafeorrisky

Ejemplares similares